Genomtec SA (4VI) Financial Statements
Genomtec SA Financial Overview
Genomtec SA's market cap is currently $10.01M. The company's EPS TTM is $-0.53; its P/E ratio is -4.92; Genomtec SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 21.00K | $ 1.00K | $ 1.00K | $ 40.00K | $ 219.00K |
| Gross Profit | $ -2.78M | $ 1.00K | $ -793.00K | $ -817.00K | $ -376.00K |
| Operating Income | $ -14.78M | $ -11.05M | $ -8.73M | $ -11.95M | $ -10.54M |
| EBITDA | $ -11.98M | $ -8.72M | $ -7.76M | $ -11.06M | $ -6.58M |
| Net Income | $ -10.43M | $ -11.21M | $ -9.01M | $ -11.93M | $ -7.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.72M | $ 6.70M | $ 4.17M | $ 4.14M | $ 1.38M |
| Total Assets | $ 15.42M | $ 17.04M | $ 15.97M | $ 11.80M | $ 4.22M |
| Total Debt | $ 1.82M | $ 2.74M | $ 1.99M | $ 2.28M | $ 1.75M |
| Net Debt | $ -2.90M | $ -3.96M | $ -2.18M | $ -1.86M | $ 363.00K |
| Total Liabilities | $ 4.71M | $ 9.44M | $ 7.67M | $ 6.87M | $ 3.48M |
| Stockholders' Equity | $ 9.21M | $ 7.60M | $ 8.30M | $ 4.89M | $ 723.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -11.48M | $ -6.78M | $ -11.48M | $ -8.12M | $ -5.74M |
| Operating Cash Flow | $ -11.38M | $ -6.72M | $ -7.95M | $ -3.79M | $ -5.53M |
| Investing Cash Flow | $ -92.00K | $ -380.00K | $ -3.80M | $ -4.33M | $ -213.00K |
| Financing Cash Flow | $ 9.50M | $ 9.62M | $ 11.80M | $ 10.89M | $ -196.00K |
Currency in PLN
